Clinical Trial: Remibrutinib in Real-world Clinical Practice - a South Korea Sub-Study

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07920315) titled 'Remibrutinib in Real-world Clinical Practice - a South Korea Sub-Study' on Oct. 30.

Brief Summary: Prospective, non-interventional study in patients with chronic spontaneous urticaria (CSU) where the treatment decision prior enrollment has been made to escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical practice population.

Study Start Date: Nov. 30

Study Type: OBSERVATIONAL

Condition: Chronic Spontaneous Urticaria

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Nov...